ACADIA PHARMACEUTICALS INC. Proceeds from Contributed Capital
ACADIA PHARMACEUTICALS INC. (ACAD) reported Proceeds from Contributed Capital of $14.32 million for the 12-month period ending 2016-12-31, per its 10-K filed 2019-02-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromContributedCapital · last filed 2019-02-27
- ACADIA PHARMACEUTICALS INC. proceeds from contributed capital for the quarter ending 2016-12-31 was $0.00.
- ACADIA PHARMACEUTICALS INC. proceeds from contributed capital for the quarter ending 2016-09-30 was $0.00.
- ACADIA PHARMACEUTICALS INC. proceeds from contributed capital for fiscal 2016 was $14.32M.
| Period end | Proceeds from Contributed Capital 1 month | Proceeds from Contributed Capital 3 month | Proceeds from Contributed Capital 6 month | Proceeds from Contributed Capital 9 month | Proceeds from Contributed Capital 12 month |
|---|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $0.00 derived: sum of 2 quarters · filed 2019-02-27 | $14.32M 10-K · filed 2019-02-27 | ||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $14.32M 10-Q · filed 2017-11-07 | |||
| 2016-06-30 | $14.32M 10-Q · filed 2017-08-08 | ||||
| 2016-04-30 | $14.30M 10-K · filed 2019-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |